Pfizer 5 XNB (Inlyta 5 mg)
Generic Name: axitinib
Pill imprint Pfizer 5 XNB has been identified as Inlyta 5 mg.
Inlyta is used in the treatment of renal cell carcinoma and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Inlyta 5 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for Pfizer 5 XNB (Inlyta 5 mg)
- Generic Name:
- 5 mg
- Prescription only
- Drug Class:
- Multikinase inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Pfizer Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- microcrystalline cellulose
ferric oxide red
hypromellose 2910 (15000 mPa.s)
Inlyta is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...